Rethink what you know about peptides.

Science-first peptide education. No hype, no sales pitch. Just evidence.

Ozempic, Wegovy & the GLP-1 Revolution

The weight loss drugs reshaping medicine — what the trials show, what happens when you stop, and what’s coming next.

→What Happens When You Stop Taking Semaglutide?→Tirzepatide vs Semaglutide: Which One Leads to More Weight Loss?→Retatrutide: The Triple Agonist That Could Change Weight Loss →Orforglipron: The Oral GLP-1 That Could Disrupt Everything →GLP-1 Drugs and Addiction: The Unexpected Discovery →Caloric Intake on GLP-1 Therapy: How Low Is Too Low?

All Weight Loss Topics →

BPC-157, TB-500 & the FDA Crackdown

The most popular underground peptides just got banned. Here’s what the science actually says — and what the FDA did.

→The Real BPC-157 Story: 544 Papers, 30 Human Subjects →BPC-157 and the FDA: Category 2 Explained →Which 14 Peptides Are Moving Back to Category 1?→BPC-157 Legal Status in 2026: Where Things Stand →“For Research Use Only”: The Legal Fiction of Gray Market Peptides →BPC-157 and TB-500 in Bodybuilding: The Injury Prevention Narrative

All BPC-157 Research →

Anti-Aging & Longevity Peptides

GHK-Cu, Epithalon, MOTS-c, and the molecules being studied to slow biological aging.

→GHK-Cu: The Copper Peptide That Modulates 4,000 Genes →Epithalon: The Telomerase-Activating Peptide →MOTS-c: The Mitochondrial Peptide That Mimics Exercise →Humanin: The Cytoprotective Peptide from Your Mitochondria →Telomeres and Aging: The Biological Clock →Sirtuins and Peptide Regulation: The Longevity Connection

All Anti-Aging Topics →

Brain, Mood & Nootropic Peptides

Selank, Semax, Cerebrolysin, Dihexa — what the research says about peptides for cognitive enhancement.

→Selank: The Anxiolytic Peptide and What Research Shows →Selank vs Semax: How Two Russian Neuropeptides Compare →How Semax Upregulates BDNF: The Neuroplasticity Mechanism →Cerebrolysin: The Neurotrophic Peptide Used in Stroke Recovery →Dihexa: The Peptide Described as Millions of Times More Potent Than BDNF →Neuropeptides and Depression: The Biology Beyond Serotonin

All Brain & Nootropic Topics →

Collagen & Skin Peptides That Actually Work

Clinical trial data on collagen supplements, copper peptides, and cosmetic peptides — separating evidence from marketing.

→Do Collagen Supplements Work? What Trials Show →GHK-Cu for Skin: What the Clinical Evidence Shows →Collagen Peptides for Athletes: Tendon and Ligament Evidence →Argireline: The ‘Botox in a Bottle’ Peptide →Peptides for Hair Loss: What the Research Shows →Copper Peptides in Skincare: The Science Behind the Buzz

All Skin & Collagen Topics →

Growth Hormone Peptides: MK-677, Ipamorelin, CJC-1295

How they work, how they compare, and the side effects nobody talks about.

→MK-677 (Ibutamoren): The Oral Growth Hormone Secretagogue →MK-677 and Insulin Resistance: The Blood Sugar Trade-Off →Ipamorelin: The Selective GH Secretagogue →CJC-1295 DAC vs No DAC: Key Differences →Can Growth Hormone Peptides Build Muscle? Hype vs Evidence →How Growth Hormone Peptides Affect Sleep Quality

All Growth Hormone Topics →

Sexual Health & Hormonal Peptides

PT-141, oxytocin, kisspeptin, and the peptides that influence desire, fertility, and reproductive health.

→Vyleesi for Women: The Clinical Evidence on Hypoactive Sexual Desire →Melanotan II and Erections: The Accidental Discovery →Kisspeptin: The Peptide That Triggers Puberty and Drives Desire →Oxytocin and Female Sexual Response: The Bonding-Arousal Connection →PT-141 vs Viagra: Fundamentally Different Mechanisms →Peptide Hormone Dysregulation in PCOS: What Goes Wrong

All Sexual Health & Hormone Topics →

Why trust RethinkPeptides?

7300+

Peer-reviewed studies indexed, tagged, and summarized in plain English.

No affiliate links. No product sales. No vendor relationships. Zero commercial bias.

We don't sell peptides. We don't take commissions. Every article links directly to the research it cites. Our only goal is giving you the unbiased information you need to make informed decisions.

Browse the Research Database →Editorial Policy